CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy
about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesBiological evaluation of 131I- and CF750-labeled Dmab(scFv)-Fc antibodies for xenograft imaging of CD25-positive tumors.Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis.Naso-Sinusal T ALL With Aberrant Expression of CD56 Mimicking NK/T Non Hodgkin Lymphoma.Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.
P2860
Q24604581-1E2BFCBB-CA15-474F-AE81-66B4B4C7FFD9Q33597766-34BA4268-1D28-4CE5-B486-718DADA54E80Q36797960-620063D3-F08C-408C-B94E-44E6FE04B7CDQ38000087-1B9D2E4C-BD83-4647-8484-6D98133A311DQ42152353-A63EB95F-F3CF-4EDD-B4E0-9066B9646875Q42938458-4D294859-2A9B-48FB-AEE1-66CD95456AB2Q49838769-A1E3DFA4-B58B-44AD-85AE-BA4D72145AABQ49964009-CE419C57-92D9-4445-BD32-4806221EC18F
P2860
CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD56 expression in T-cell acut ...... val after risk-adapted therapy
@en
CD56 expression in T-cell acut ...... al after risk-adapted therapy.
@nl
type
label
CD56 expression in T-cell acut ...... val after risk-adapted therapy
@en
CD56 expression in T-cell acut ...... al after risk-adapted therapy.
@nl
prefLabel
CD56 expression in T-cell acut ...... val after risk-adapted therapy
@en
CD56 expression in T-cell acut ...... al after risk-adapted therapy.
@nl
P2093
P2860
P356
P1433
P1476
CD56 expression in T-cell acut ...... val after risk-adapted therapy
@en
P2093
Dieter Hoelzer
Eckhard Thiel
Harald Rieder
Lars Fischer
Monika Brüggemann
Nicola Gökbuget
Stefan Schwartz
P2860
P304
P356
10.3324/HAEMATOL.13543
P577
2008-12-23T00:00:00Z